Company
About the company
Bristol Myers Squibb UK supplies prescription medicines and conducts clinical, medical and commercial activities, with a focus on oncology, haematology, immunology, cardiovascular disease and neuroscience. It works with the NHS, clinicians, researchers and patient organisations. The UK business forms part of a United States-headquartered global biopharmaceutical company.
Company statement
Carbon claim
Bristol Myers Squibb publishes SBTi-validated emissions targets and a commitment to achieve net-zero greenhouse-gas emissions across its value chain by 2050.
A short summary of publicly available information. We have not verified the carbon claim.
Read the public source